Ematologia

Improved survival and treatment for chronic blood disorders

New research from Karolinska Institutet shows that hydroxyurea, one type of cytotoxic treatment for chronic myeloproliferative blood disorders, does not increase the risk of developing acute leukaemia, as had previously been suspected. Rather, it is the disease itself that mainly increases this risk. Another new study by the same group of researchers shows that mortality from chronic myeloid leukaemia has decreased sharply since the approval of the drug Imatinib as a standard treatment in 2001.
Approfondisci

 http://ki.se/ki/jsp/polopoly.jsp?d=130&a=122576&l=en&newsdep...

Karolinska Institutet